Grundinformationen
- Standard-SMILES
C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=O- InChIKey
MMSNEKOTSJRTRI-LLVKDONJSA-N- Summenformel
- C16H15FN2O2S
- Durchschnittliche Molmasse
- 318,4 g/mol
- Monoisotopische Masse
- 318,08382694
Überblick
Atreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.
Namen und Bezeichner
- Bevorzugter Name
- Atreleuton
- IUPAC
- 1-[(2R)-4-[5-[(4-fluorophenyl)methyl]thiophen-2-yl]but-3-yn-2-yl]-1-hydroxyurea
- Englischer Name
- ATRELEUTON
- Summenformel
- C16H15FN2O2S
- Molmasse
- 318.37
Namen und Synonyme
Atreleuton154355-76-7Abbott-85761VIA-2291VIA2291U301T88E1M1-[(2R)-4-[5-[(4-fluorophenyl)methyl]thiophen-2-yl]but-3-yn-2-yl]-1-hydroxyureaA-85761.0A-85761DTXSID10165598atreleutonum1-((2R)-4-(5-((4-fluorophenyl)methyl)thiophen-2-yl)but-3-yn-2-yl)-1-hydroxyurea
Weitere Namen anzeigen
COX/5-LO-IN-1Atreleuton analogCOX/5LOIN1,COX/5 LO IN 1Urea, N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propyn-1-yl]-N-hydroxy-
RefChem:560332DTXCID1088089N-(3-(5-((4-fluorophenyl)methyl)-2-thienyl)-1-methyl-2-propynyl)-N-hydroxyurea((R)-3-(5-(p-Fluorobenzyl)-2-thienyl)-1-methyl-2-propynyl)-1-hydroxyureaABT-761ABT 761Atreleuton [USAN:INN]VIA 2291
Datenbank-Bezeichner
- CAS
154355-75-6、154355-76-7- PubChem CID
- 3086671
- DTXSID
DTXSID10165598- ChEMBL
CHEMBL59356- UNII
- U301T88E1M
- EC Number
- 604-947-6
- Nikkaji
- J710.520G
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,7
- Polarare Oberfläche (TPSA)
- 94,8 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 4
- Schwere Atome
- 22
- Formalladung
- 0
- Komplexität
- 454
Experimentelle und physikochemische Eigenschaften
DrugsPharmaceuticals -> Listed in ZINC15
Physikochemische Eigenschaften
- Siedepunkt
- 506.7 · 506.7±60.0 °C(Predicted)
- Dichte
- 1.37 · 1.37±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- Soluble in DMSO
- pka
- 9.63 · 9.63±0.50(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological ClassificationCompounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES.
Anwendungen
VerwendenAnti-asthmatic; inhibitor (5-lipoxygenase).
Anbieter14 Anbieter
南京世洲生物科技有限公司025-025-85560043 17301488900 · [email protected]
上海赛可锐生物科技有限公司021-58000709 13120558703 · [email protected]
Clearsynth Labs Limited+91-22-26355700 · [email protected]
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
上海一飞生物科技有限公司021-65675885 18964387627 · [email protected]
上海超岚化工科技中心QQ:65489617 13301690235 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
南京世洲生物科技有限公司025-85560043 15850508050 · [email protected]
南京世洲生物科技有限公司18351873721 · [email protected]
Zugehörige Reaktionen
5
Verknüpfte Notizen
Wird geladen…